<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31861356</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2073-4409</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cells</Title>
          <ISOAbbreviation>Cells</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Metabolic Reprogramming in Mitochondria of Myeloid Cells.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">5</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9010005</ELocationID>
        <Abstract>
          <AbstractText>The myeloid lineage consists of multiple immune cell types, such as macrophages, monocytes, and dendritic cells. It actively participates in both innate and adaptive immunity. In response to pro- or anti-inflammatory signals, these cells undergo distinct programmed metabolic changes especially in mitochondria. Pro-inflammatory signals induce not only a simple shift from oxidative phosphorylation to glycolysis, but also complicated metabolic alterations during the early and tolerant stages in myeloid cells. In mitochondria, a broken Krebs cycle leads to the accumulation of two metabolites, citrate and succinate, both of which trigger pro-inflammatory responses of myeloid cells. A deficient electron transport chain induces pro-inflammatory responses in the resting myeloid cells while it suppresses these responses in the polarized cells during inflammation. The metabolic reprogramming in mitochondria is also associated with altered mitochondrial morphology. On the other hand, intact oxidative phosphorylation is required for the anti-inflammatory functions of myeloid cells. Fatty acid synthesis is essential for the pro-inflammatory effect and glutamine metabolism in mitochondria exhibits the anti-inflammatory effect. A few aspects of metabolic reprogramming remain uncertain, for example, glycolysis and fatty acid oxidation in anti-inflammation. Overall, metabolic reprogramming is an important element of immune responses in myeloid cells.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zuo</LastName>
            <ForeName>Hao</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0002-8812-7385</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wan</LastName>
            <ForeName>Yihong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hamon Center for Regenerative Science and Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 CA229487</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA236802</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cells</MedlineTA>
        <NlmUniqueID>101600052</NlmUniqueID>
        <ISSNLinking>2073-4409</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D056704" MajorTopicYN="N">Adaptive Immunity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002952" MajorTopicYN="N">Citric Acid Cycle</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006019" MajorTopicYN="N">Glycolysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D022423" MajorTopicYN="N">Myeloid Cells</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010085" MajorTopicYN="N">Oxidative Phosphorylation</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Krebs cycle</Keyword>
        <Keyword MajorTopicYN="Y">electron transport chain</Keyword>
        <Keyword MajorTopicYN="Y">glycolysis</Keyword>
        <Keyword MajorTopicYN="Y">inflammation</Keyword>
        <Keyword MajorTopicYN="Y">macrophages</Keyword>
        <Keyword MajorTopicYN="Y">metabolism</Keyword>
        <Keyword MajorTopicYN="Y">mitochondria</Keyword>
        <Keyword MajorTopicYN="Y">myeloid cells</Keyword>
        <Keyword MajorTopicYN="Y">oxidative phosphorylation</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31861356</ArticleId>
        <ArticleId IdType="pmc">PMC7017304</ArticleId>
        <ArticleId IdType="doi">10.3390/cells9010005</ArticleId>
        <ArticleId IdType="pii">cells9010005</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Villavicencio M., Guzman Barron E.S. Pathways of glucose metabolism in lymphatic cells of rabbit’s appendix and Gardners’s mouse lymphosarcoma. Arch. Biochem. Biophys. 1957;67:121–137. doi: 10.1016/0003-9861(57)90251-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0003-9861(57)90251-5</ArticleId>
            <ArticleId IdType="pubmed">13412126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oren R., Farnham A.E., Saito K., Milofsky E., Karnovsky M.L. Metabolic patterns in three types of phagocytizing cells. J. Cell Biol. 1963;17:487–501. doi: 10.1083/jcb.17.3.487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.17.3.487</ArticleId>
            <ArticleId IdType="pmc">PMC2106210</ArticleId>
            <ArticleId IdType="pubmed">13940299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Neill L.A., Kishton R.J., Rathmell J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 2016;16:553–565. doi: 10.1038/nri.2016.70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri.2016.70</ArticleId>
            <ArticleId IdType="pmc">PMC5001910</ArticleId>
            <ArticleId IdType="pubmed">27396447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buck M.D., O’Sullivan D., Pearce E.L. T cell metabolism drives immunity. J. Exp. Med. 2015;212:1345–1360. doi: 10.1084/jem.20151159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20151159</ArticleId>
            <ArticleId IdType="pmc">PMC4548052</ArticleId>
            <ArticleId IdType="pubmed">26261266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwasaki H., Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity. 2007;26:726–740. doi: 10.1016/j.immuni.2007.06.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2007.06.004</ArticleId>
            <ArticleId IdType="pubmed">17582345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forman H.J., Torres M. Reactive oxygen species and cell signaling: Respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 2002;166:S4–S8. doi: 10.1164/rccm.2206007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.2206007</ArticleId>
            <ArticleId IdType="pubmed">12471082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Youle R.J., van der Bliek A.M. Mitochondrial fission, fusion, and stress. Science. 2012;337:1062–1065. doi: 10.1126/science.1219855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1219855</ArticleId>
            <ArticleId IdType="pmc">PMC4762028</ArticleId>
            <ArticleId IdType="pubmed">22936770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lanca T., Silva-Santos B. The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy. Oncoimmunology. 2012;1:717–725. doi: 10.4161/onci.20068.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/onci.20068</ArticleId>
            <ArticleId IdType="pmc">PMC3429575</ArticleId>
            <ArticleId IdType="pubmed">22934263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Covarrubias A.J., Aksoylar H.I., Horng T. Control of macrophage metabolism and activation by mTOR and Akt signaling. Semin. Immunol. 2015;27:286–296. doi: 10.1016/j.smim.2015.08.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.smim.2015.08.001</ArticleId>
            <ArticleId IdType="pmc">PMC4682888</ArticleId>
            <ArticleId IdType="pubmed">26360589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Neill L.A., Hardie D.G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature. 2013;493:346–355. doi: 10.1038/nature11862.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11862</ArticleId>
            <ArticleId IdType="pubmed">23325217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haschemi A., Kosma P., Gille L., Evans C.R., Burant C.F., Starkl P., Knapp B., Haas R., Schmid J.A., Jandl C., et al.  The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab. 2012;15:813–826. doi: 10.1016/j.cmet.2012.04.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2012.04.023</ArticleId>
            <ArticleId IdType="pmc">PMC3370649</ArticleId>
            <ArticleId IdType="pubmed">22682222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tannahill G.M., Curtis A.M., Adamik J., Palsson-McDermott E.M., McGettrick A.F., Goel G., Frezza C., Bernard N.J., Kelly B., Foley N.H., et al.  Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature. 2013;496:238–242. doi: 10.1038/nature11986.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11986</ArticleId>
            <ArticleId IdType="pmc">PMC4031686</ArticleId>
            <ArticleId IdType="pubmed">23535595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langston P.K., Nambu A., Jung J., Shibata M., Aksoylar H.I., Lei J., Xu P., Doan M.T., Jiang H., MacArthur M.R., et al.  Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses. Nat. Immunol. 2019;20:1186–1195. doi: 10.1038/s41590-019-0453-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41590-019-0453-7</ArticleId>
            <ArticleId IdType="pmc">PMC6707851</ArticleId>
            <ArticleId IdType="pubmed">31384058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cameron A.M., Castoldi A., Sanin D.E., Flachsmann L.J., Field C.S., Puleston D.J., Kyle R.L., Patterson A.E., Hassler F., Buescher J.M., et al.  Inflammatory macrophage dependence on NAD(+) salvage is a consequence of reactive oxygen species-mediated DNA damage. Nat. Immunol. 2019;20:420–432. doi: 10.1038/s41590-019-0336-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41590-019-0336-y</ArticleId>
            <ArticleId IdType="pubmed">30858618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baseler W.A., Davies L.C., Quigley L., Ridnour L.A., Weiss J.M., Hussain S.P., Wink D.A., McVicar D.W. Autocrine IL-10 functions as a rheostat for M1 macrophage glycolytic commitment by tuning nitric oxide production. Redox Biol. 2016;10:12–23. doi: 10.1016/j.redox.2016.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.redox.2016.09.005</ArticleId>
            <ArticleId IdType="pmc">PMC5037266</ArticleId>
            <ArticleId IdType="pubmed">27676159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang F., Zhang S., Vuckovic I., Jeon R., Lerman A., Folmes C.D., Dzeja P.P., Herrmann J. Glycolytic stimulation is not a requirement for m2 macrophage differentiation. Cell Metab. 2018;28:463–475. doi: 10.1016/j.cmet.2018.08.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2018.08.012</ArticleId>
            <ArticleId IdType="pmc">PMC6449248</ArticleId>
            <ArticleId IdType="pubmed">30184486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez-Prados J.C., Traves P.G., Cuenca J., Rico D., Aragones J., Martin-Sanz P., Cascante M., Bosca L. Substrate fate in activated macrophages: A comparison between innate, classic, and alternative activation. J. Immunol. 2010;185:605–614. doi: 10.4049/jimmunol.0901698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0901698</ArticleId>
            <ArticleId IdType="pubmed">20498354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lachmandas E., Boutens L., Ratter J.M., Hijmans A., Hooiveld G.J., Joosten L.A., Rodenburg R.J., Fransen J.A., Houtkooper R.H., van Crevel R., et al.  Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes. Nat. Microbiol. 2016;2:16246. doi: 10.1038/nmicrobiol.2016.246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nmicrobiol.2016.246</ArticleId>
            <ArticleId IdType="pubmed">27991883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raulien N., Friedrich K., Strobel S., Rubner S., Baumann S., von Bergen M., Korner A., Krueger M., Rossol M., Wagner U. Fatty acid oxidation compensates for lipopolysaccharide-induced warburg effect in glucose-deprived monocytes. Front. Immunol. 2017;8:609. doi: 10.3389/fimmu.2017.00609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.00609</ArticleId>
            <ArticleId IdType="pmc">PMC5447039</ArticleId>
            <ArticleId IdType="pubmed">28611773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Everts B., Amiel E., van der Windt G.J., Freitas T.C., Chott R., Yarasheski K.E., Pearce E.L., Pearce E.J. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood. 2012;120:1422–1431. doi: 10.1182/blood-2012-03-419747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2012-03-419747</ArticleId>
            <ArticleId IdType="pmc">PMC3423780</ArticleId>
            <ArticleId IdType="pubmed">22786879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Everts B., Amiel E., Huang S.C., Smith A.M., Chang C.H., Lam W.Y., Redmann V., Freitas T.C., Blagih J., van der Windt G.J., et al.  TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation. Nat. Immunol. 2014;15:323–332. doi: 10.1038/ni.2833.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.2833</ArticleId>
            <ArticleId IdType="pmc">PMC4358322</ArticleId>
            <ArticleId IdType="pubmed">24562310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palsson-McDermott E.M., Curtis A.M., Goel G., Lauterbach M.A., Sheedy F.J., Gleeson L.E., van den Bosch M.W., Quinn S.R., Domingo-Fernandez R., Johnston D.G., et al.  Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 2015;21:65–80. doi: 10.1016/j.cmet.2014.12.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2014.12.005</ArticleId>
            <ArticleId IdType="pmc">PMC5198835</ArticleId>
            <ArticleId IdType="pubmed">25565206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu L., Lu Y., Martinez J., Bi Y., Lian G., Wang T., Milasta S., Wang J., Yang M., Liu G., et al.  Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1alpha-dependent. Proc. Natl. Acad. Sci. USA. 2016;113:1564–1569. doi: 10.1073/pnas.1518000113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1518000113</ArticleId>
            <ArticleId IdType="pmc">PMC4760828</ArticleId>
            <ArticleId IdType="pubmed">26811453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mills E.L., Kelly B., Logan A., Costa A.S.H., Varma M., Bryant C.E., Tourlomousis P., Dabritz J.H.M., Gottlieb E., Latorre I., et al.  Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell. 2016;167:457–470. doi: 10.1016/j.cell.2016.08.064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2016.08.064</ArticleId>
            <ArticleId IdType="pmc">PMC5863951</ArticleId>
            <ArticleId IdType="pubmed">27667687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nemeth B., Doczi J., Csete D., Kacso G., Ravasz D., Adams D., Kiss G., Nagy A.M., Horvath G., Tretter L., et al.  Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2016;30:286–300. doi: 10.1096/fj.15-279398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.15-279398</ArticleId>
            <ArticleId IdType="pubmed">26358042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ip W.K.E., Hoshi N., Shouval D.S., Snapper S., Medzhitov R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017;356:513–519. doi: 10.1126/science.aal3535.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.aal3535</ArticleId>
            <ArticleId IdType="pmc">PMC6260791</ArticleId>
            <ArticleId IdType="pubmed">28473584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vijayan V., Pradhan P., Braud L., Fuchs H.R., Gueler F., Motterlini R., Foresti R., Immenschuh S. Human and murine macrophages exhibit differential metabolic responses to lipopolysaccharide—A divergent role for glycolysis. Redox Biol. 2019;22:101147. doi: 10.1016/j.redox.2019.101147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.redox.2019.101147</ArticleId>
            <ArticleId IdType="pmc">PMC6396203</ArticleId>
            <ArticleId IdType="pubmed">30825774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng S.C., Quintin J., Cramer R.A., Shepardson K.M., Saeed S., Kumar V., Giamarellos-Bourboulis E.J., Martens J.H., Rao N.A., Aghajanirefah A., et al.  mTOR-and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014;345:1250684. doi: 10.1126/science.1250684.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1250684</ArticleId>
            <ArticleId IdType="pmc">PMC4226238</ArticleId>
            <ArticleId IdType="pubmed">25258083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng S.C., Scicluna B.P., Arts R.J., Gresnigt M.S., Lachmandas E., Giamarellos-Bourboulis E.J., Kox M., Manjeri G.R., Wagenaars J.A., Cremer O.L., et al.  Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat. Immunol. 2016;17:406–413. doi: 10.1038/ni.3398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.3398</ArticleId>
            <ArticleId IdType="pubmed">26950237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scrima R., Menga M., Pacelli C., Agriesti F., Cela O., Piccoli C., Cotoia A., De Gregorio A., Gefter J.V., Cinnella G., et al.  Para-hydroxyphenylpyruvate inhibits the pro-inflammatory stimulation of macrophage preventing LPS-mediated nitro-oxidative unbalance and immunometabolic shift. PLoS ONE. 2017;12:e0188683.  doi: 10.1371/journal.pone.0188683.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0188683</ArticleId>
            <ArticleId IdType="pmc">PMC5703549</ArticleId>
            <ArticleId IdType="pubmed">29176872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y., Jia A., Wang Y., Dong L., Wang Y., He Y., Wang S., Cao Y., Yang H., Bi Y., et al.  Immune effects of glycolysis or oxidative phosphorylation metabolic pathway in protecting against bacterial infection. J. Cell. Physiol. 2019;234:20298–20309. doi: 10.1002/jcp.28630.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.28630</ArticleId>
            <ArticleId IdType="pubmed">30972784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krawczyk C.M., Holowka T., Sun J., Blagih J., Amiel E., DeBerardinis R.J., Cross J.R., Jung E., Thompson C.B., Jones R.G., et al.  Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115:4742–4749. doi: 10.1182/blood-2009-10-249540.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2009-10-249540</ArticleId>
            <ArticleId IdType="pmc">PMC2890190</ArticleId>
            <ArticleId IdType="pubmed">20351312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amiel E., Everts B., Fritz D., Beauchamp S., Ge B., Pearce E.L., Pearce E.J. Mechanistic target of rapamycin inhibition extends cellular lifespan in dendritic cells by preserving mitochondrial function. J. Immunol. 2014;193:2821–2830. doi: 10.4049/jimmunol.1302498.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1302498</ArticleId>
            <ArticleId IdType="pmc">PMC4302759</ArticleId>
            <ArticleId IdType="pubmed">25108022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hargrave K.E., Woods S., Millington O., Chalmers S., Westrop G.D., Roberts C.W. Multi-omics studies demonstrate toxoplasma gondii-induced metabolic reprogramming of murine dendritic cells. Front. Cell. Infect. Microbiol. 2019;9:309. doi: 10.3389/fcimb.2019.00309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2019.00309</ArticleId>
            <ArticleId IdType="pmc">PMC6749083</ArticleId>
            <ArticleId IdType="pubmed">31572687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nair S., Sobotka K.S., Joshi P., Gressens P., Fleiss B., Thornton C., Mallard C., Hagberg H. Lipopolysaccharide-induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivo. Glia. 2019;67:1047–1061. doi: 10.1002/glia.23587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.23587</ArticleId>
            <ArticleId IdType="pubmed">30637805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saeed S., Quintin J., Kerstens H.H., Rao N.A., Aghajanirefah A., Matarese F., Cheng S.C., Ratter J., Berentsen K., van der Ent M.A., et al.  Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science. 2014;345:1251086. doi: 10.1126/science.1251086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1251086</ArticleId>
            <ArticleId IdType="pmc">PMC4242194</ArticleId>
            <ArticleId IdType="pubmed">25258085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seeley J.J., Ghosh S. Molecular mechanisms of innate memory and tolerance to LPS. J. Leukoc. Biol. 2017;101:107–119. doi: 10.1189/jlb.3MR0316-118RR.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.3MR0316-118RR</ArticleId>
            <ArticleId IdType="pubmed">27780875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vats D., Mukundan L., Odegaard J.I., Zhang L., Smith K.L., Morel C.R., Wagner R.A., Greaves D.R., Murray P.J., Chawla A. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006;4:13–24. doi: 10.1016/j.cmet.2006.05.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2006.05.011</ArticleId>
            <ArticleId IdType="pmc">PMC1904486</ArticleId>
            <ArticleId IdType="pubmed">16814729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Covarrubias A.J., Aksoylar H.I., Yu J., Snyder N.W., Worth A.J., Iyer S.S., Wang J., Ben-Sahra I., Byles V., Polynne-Stapornkul T., et al.  Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. eLife. 2016;5:e11612. doi: 10.7554/eLife.11612.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.11612</ArticleId>
            <ArticleId IdType="pmc">PMC4769166</ArticleId>
            <ArticleId IdType="pubmed">26894960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang S.C., Smith A.M., Everts B., Colonna M., Pearce E.L., Schilling J.D., Pearce E.J. Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation. Immunity. 2016;45:817–830. doi: 10.1016/j.immuni.2016.09.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2016.09.016</ArticleId>
            <ArticleId IdType="pmc">PMC5535820</ArticleId>
            <ArticleId IdType="pubmed">27760338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J., Choi H., Min J.S., Park S.J., Kim J.H., Park H.J., Kim B., Chae J.I., Yim M., Lee D.S. Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells. J. Neurochem. 2013;127:221–232. doi: 10.1111/jnc.12361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jnc.12361</ArticleId>
            <ArticleId IdType="pubmed">23815397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katoh M., Wu B., Nguyen H.B., Thai T.Q., Yamasaki R., Lu H., Rietsch A.M., Zorlu M.M., Shinozaki Y., Saitoh Y., et al.  Polymorphic regulation of mitochondrial fission and fusion modifies phenotypes of microglia in neuroinflammation. Sci. Rep. 2017;7:4942. doi: 10.1038/s41598-017-05232-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-017-05232-0</ArticleId>
            <ArticleId IdType="pmc">PMC5503944</ArticleId>
            <ArticleId IdType="pubmed">28694451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Esteban-Martinez L., Sierra-Filardi E., McGreal R.S., Salazar-Roa M., Marino G., Seco E., Durand S., Enot D., Grana O., Malumbres M., et al.  Programmed mitophagy is essential for the glycolytic switch during cell differentiation. EMBO J. 2017;36:1688–1706. doi: 10.15252/embj.201695916.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15252/embj.201695916</ArticleId>
            <ArticleId IdType="pmc">PMC5470043</ArticleId>
            <ArticleId IdType="pubmed">28465321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao Z., Li Y., Wang F., Huang T., Fan K., Zhang Y., Zhong J., Cao Q., Chao T., Jia J., et al.  Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability. Nat. Commun. 2017;8:1805. doi: 10.1038/s41467-017-01919-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-017-01919-0</ArticleId>
            <ArticleId IdType="pmc">PMC5703766</ArticleId>
            <ArticleId IdType="pubmed">29180626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cassidy-Stone A., Chipuk J.E., Ingerman E., Song C., Yoo C., Kuwana T., Kurth M.J., Shaw J.T., Hinshaw J.E., Green D.R., et al.  Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev. Cell. 2008;14:193–204. doi: 10.1016/j.devcel.2007.11.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2007.11.019</ArticleId>
            <ArticleId IdType="pmc">PMC2267902</ArticleId>
            <ArticleId IdType="pubmed">18267088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Subramanian M., Yurdagul A., Jr., Barbosa-Lorenzi V.C., Cai B., de Juan-Sanz J., Ryan T.A., Nomura M., Maxfield F.R., Tabas I. Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages. Cell. 2017;171:331–345. doi: 10.1016/j.cell.2017.08.041.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2017.08.041</ArticleId>
            <ArticleId IdType="pmc">PMC5679712</ArticleId>
            <ArticleId IdType="pubmed">28942921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bordt E.A., Clerc P., Roelofs B.A., Saladino A.J., Tretter L., Adam-Vizi V., Cherok E., Khalil A., Yadava N., Ge S.X., et al.  The putative Drp1 inhibitor mdivi-1 is a reversible mitochondrial complex I inhibitor that modulates reactive oxygen species. Dev. Cell. 2017;40:583–594. doi: 10.1016/j.devcel.2017.02.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2017.02.020</ArticleId>
            <ArticleId IdType="pmc">PMC5398851</ArticleId>
            <ArticleId IdType="pubmed">28350990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Twig G., Shirihai O.S. The interplay between mitochondrial dynamics and mitophagy. Antioxid. Redox Signal. 2011;14:1939–1951. doi: 10.1089/ars.2010.3779.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2010.3779</ArticleId>
            <ArticleId IdType="pmc">PMC3078508</ArticleId>
            <ArticleId IdType="pubmed">21128700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221–225. doi: 10.1038/nature09663.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature09663</ArticleId>
            <ArticleId IdType="pubmed">21124315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhong Z., Umemura A., Sanchez-Lopez E., Liang S., Shalapour S., Wong J., He F., Boassa D., Perkins G., Ali S.R., et al.  NF-kappaB restricts inflammasome activation via elimination of damaged mitochondria. Cell. 2016;164:896–910. doi: 10.1016/j.cell.2015.12.057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2015.12.057</ArticleId>
            <ArticleId IdType="pmc">PMC4769378</ArticleId>
            <ArticleId IdType="pubmed">26919428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jha A.K., Huang S.C., Sergushichev A., Lampropoulou V., Ivanova Y., Loginicheva E., Chmielewski K., Stewart K.M., Ashall J., Everts B., et al.  Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42:419–430. doi: 10.1016/j.immuni.2015.02.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2015.02.005</ArticleId>
            <ArticleId IdType="pubmed">25786174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Infantino V., Convertini P., Cucci L., Panaro M.A., Di Noia M.A., Calvello R., Palmieri F., Iacobazzi V. The mitochondrial citrate carrier: A new player in inflammation. Biochem. J. 2011;438:433–436. doi: 10.1042/BJ20111275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20111275</ArticleId>
            <ArticleId IdType="pubmed">21787310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wellen K.E., Hatzivassiliou G., Sachdeva U.M., Bui T.V., Cross J.R., Thompson C.B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 2009;324:1076–1080. doi: 10.1126/science.1164097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1164097</ArticleId>
            <ArticleId IdType="pmc">PMC2746744</ArticleId>
            <ArticleId IdType="pubmed">19461003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strelko C.L., Lu W., Dufort F.J., Seyfried T.N., Chiles T.C., Rabinowitz J.D., Roberts M.F. Itaconic acid is a mammalian metabolite induced during macrophage activation. J. Am. Chem. Soc. 2011;133:16386–16389. doi: 10.1021/ja2070889.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ja2070889</ArticleId>
            <ArticleId IdType="pmc">PMC3216473</ArticleId>
            <ArticleId IdType="pubmed">21919507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michelucci A., Cordes T., Ghelfi J., Pailot A., Reiling N., Goldmann O., Binz T., Wegner A., Tallam A., Rausell A., et al.  Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc. Natl. Acad. Sci. USA. 2013;110:7820–7825. doi: 10.1073/pnas.1218599110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1218599110</ArticleId>
            <ArticleId IdType="pmc">PMC3651434</ArticleId>
            <ArticleId IdType="pubmed">23610393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cordes T., Wallace M., Michelucci A., Divakaruni A.S., Sapcariu S.C., Sousa C., Koseki H., Cabrales P., Murphy A.N., Hiller K., et al.  Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 2016;291:14274–14284. doi: 10.1074/jbc.M115.685792.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M115.685792</ArticleId>
            <ArticleId IdType="pmc">PMC4933182</ArticleId>
            <ArticleId IdType="pubmed">27189937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lampropoulou V., Sergushichev A., Bambouskova M., Nair S., Vincent E.E., Loginicheva E., Cervantes-Barragan L., Ma X., Huang S.C., Griss T., et al.  Itaconate Links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 2016;24:158–166. doi: 10.1016/j.cmet.2016.06.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2016.06.004</ArticleId>
            <ArticleId IdType="pmc">PMC5108454</ArticleId>
            <ArticleId IdType="pubmed">27374498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mills E.L., Ryan D.G., Prag H.A., Dikovskaya D., Menon D., Zaslona Z., Jedrychowski M.P., Costa A.S.H., Higgins M., Hams E., et al.  Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 2018;556:113–117. doi: 10.1038/nature25986.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature25986</ArticleId>
            <ArticleId IdType="pmc">PMC6047741</ArticleId>
            <ArticleId IdType="pubmed">29590092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bambouskova M., Gorvel L., Lampropoulou V., Sergushichev A., Loginicheva E., Johnson K., Korenfeld D., Mathyer M.E., Kim H., Huang L.H., et al.  Electrophilic properties of itaconate and derivatives regulate the IkappaBzeta-ATF3 inflammatory axis. Nature. 2018;556:501–504. doi: 10.1038/s41586-018-0052-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-018-0052-z</ArticleId>
            <ArticleId IdType="pmc">PMC6037913</ArticleId>
            <ArticleId IdType="pubmed">29670287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dominguez-Andres J., Novakovic B., Li Y., Scicluna B.P., Gresnigt M.S., Arts R.J.W., Oosting M., Moorlag S., Groh L.A., Zwaag J., et al.  The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity. Cell Metab. 2019;29:211–220. doi: 10.1016/j.cmet.2018.09.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2018.09.003</ArticleId>
            <ArticleId IdType="pubmed">30293776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kelly B., O’Neill L.A. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 2015;25:771–784. doi: 10.1038/cr.2015.68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cr.2015.68</ArticleId>
            <ArticleId IdType="pmc">PMC4493277</ArticleId>
            <ArticleId IdType="pubmed">26045163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallace C., Keast D. Glutamine and macrophage function. Metab. Clin. Exp. 1992;41:1016–1020. doi: 10.1016/0026-0495(92)90130-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0026-0495(92)90130-3</ArticleId>
            <ArticleId IdType="pubmed">1381459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu P.S., Wang H., Li X., Chao T., Teav T., Christen S., Di Conza G., Cheng W.C., Chou C.H., Vavakova M., et al.  alpha-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat. Immunol. 2017;18:985–994. doi: 10.1038/ni.3796.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.3796</ArticleId>
            <ArticleId IdType="pubmed">28714978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scialo F., Fernandez-Ayala D.J., Sanz A. Role of Mitochondrial Reverse Electron Transport in ROS Signaling: Potential Roles in Health and Disease. Front. Physiol. 2017;8:428. doi: 10.3389/fphys.2017.00428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2017.00428</ArticleId>
            <ArticleId IdType="pmc">PMC5486155</ArticleId>
            <ArticleId IdType="pubmed">28701960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robb E.L., Hall A.R., Prime T.A., Eaton S., Szibor M., Viscomi C., James A.M., Murphy M.P. Control of mitochondrial superoxide production by reverse electron transport at complex I. J. Biol. Chem. 2018;293:9869–9879. doi: 10.1074/jbc.RA118.003647.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.RA118.003647</ArticleId>
            <ArticleId IdType="pmc">PMC6016480</ArticleId>
            <ArticleId IdType="pubmed">29743240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koopman W.J., Verkaart S., Visch H.J., van der Westhuizen F.H., Murphy M.P., van den Heuvel L.W., Smeitink J.A., Willems P.H. Inhibition of complex I of the electron transport chain causes O2−. -mediated mitochondrial outgrowth. Am. J. Physiol. Cell Physiol. 2005;288:C1440–C1450. doi: 10.1152/ajpcell.00607.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpcell.00607.2004</ArticleId>
            <ArticleId IdType="pubmed">15647387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Votyakova T.V., Reynolds I.J. DeltaPsi(m)-Dependent and -independent production of reactive oxygen species by rat brain mitochondria. J. Neurochem. 2001;79:266–277. doi: 10.1046/j.1471-4159.2001.00548.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1471-4159.2001.00548.x</ArticleId>
            <ArticleId IdType="pubmed">11677254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y., Trush M.A. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem. Biophys. Res. Commun. 1998;253:295–299. doi: 10.1006/bbrc.1998.9729.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/bbrc.1998.9729</ArticleId>
            <ArticleId IdType="pubmed">9878531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garaude J., Acin-Perez R., Martinez-Cano S., Enamorado M., Ugolini M., Nistal-Villan E., Hervas-Stubbs S., Pelegrin P., Sander L.E., Enriquez J.A., et al.  Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense. Nat. Immunol. 2016;17:1037–1045. doi: 10.1038/ni.3509.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.3509</ArticleId>
            <ArticleId IdType="pmc">PMC4994870</ArticleId>
            <ArticleId IdType="pubmed">27348412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rembish S.J., Trush M.A. Further evidence that lucigenin-derived chemiluminescence monitors mitochondrial superoxide generation in rat alveolar macrophages. Free Radic. Biol. Med. 1994;17:117–126. doi: 10.1016/0891-5849(94)90109-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0891-5849(94)90109-0</ArticleId>
            <ArticleId IdType="pubmed">7959172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li N., Ragheb K., Lawler G., Sturgis J., Rajwa B., Melendez J.A., Robinson J.P. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 2003;278:8516–8525. doi: 10.1074/jbc.M210432200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M210432200</ArticleId>
            <ArticleId IdType="pubmed">12496265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giardina T.M., Steer J.H., Lo S.Z., Joyce D.A. Uncoupling protein-2 accumulates rapidly in the inner mitochondrial membrane during mitochondrial reactive oxygen stress in macrophages. Biochim. Biophys. Acta. 2008;1777:118–129. doi: 10.1016/j.bbabio.2007.11.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbabio.2007.11.006</ArticleId>
            <ArticleId IdType="pubmed">18082129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., Englert J.A., Rabinovitch M., Cernadas M., Kim H.P., et al.  Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011;12:222–230. doi: 10.1038/ni.1980.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.1980</ArticleId>
            <ArticleId IdType="pmc">PMC3079381</ArticleId>
            <ArticleId IdType="pubmed">21151103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>West A.P., Brodsky I.E., Rahner C., Woo D.K., Erdjument-Bromage H., Tempst P., Walsh M.C., Choi Y., Shadel G.S., Ghosh S. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011;472:476–480. doi: 10.1038/nature09973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature09973</ArticleId>
            <ArticleId IdType="pmc">PMC3460538</ArticleId>
            <ArticleId IdType="pubmed">21525932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou H., Zhang F., Chen S.H., Zhang D., Wilson B., Hong J.S., Gao H.M. Rotenone activates phagocyte NADPH oxidase by binding to its membrane subunit gp91phox. Free Radic. Biol. Med. 2012;52:303–313. doi: 10.1016/j.freeradbiomed.2011.10.488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.10.488</ArticleId>
            <ArticleId IdType="pmc">PMC3253173</ArticleId>
            <ArticleId IdType="pubmed">22094225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan Y.H., Sun J.D., Wu M.M., Hu J.F., Peng S.Y., Chen N.H. Rotenone could activate microglia through NFkappaB associated pathway. Neurochem. Res. 2013;38:1553–1560. doi: 10.1007/s11064-013-1055-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11064-013-1055-7</ArticleId>
            <ArticleId IdType="pubmed">23645222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao F., Chen D., Hu Q., Wang G. Rotenone directly induces BV2 cell activation via the p38 MAPK pathway. PLoS ONE. 2013;8:e72046.  doi: 10.1371/journal.pone.0072046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0072046</ArticleId>
            <ArticleId IdType="pmc">PMC3748029</ArticleId>
            <ArticleId IdType="pubmed">23977201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du C., Jin M., Hong Y., Li Q., Wang X.H., Xu J.M., Wang F., Zhang Y., Jia J., Liu C.F., et al.  Downregulation of cystathionine beta-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type. Biochem. Biophys. Res. Commun. 2014;451:239–245. doi: 10.1016/j.bbrc.2014.07.107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2014.07.107</ArticleId>
            <ArticleId IdType="pubmed">25086357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kelly B., Tannahill G.M., Murphy M.P., O’Neill L.A. Metformin inhibits the production of reactive oxygen species from NADH:Ubiquinone oxidoreductase to Limit Induction of Interleukin-1beta (IL-1beta) and boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated macrophages. J. Biol. Chem. 2015;290:20348–20359. doi: 10.1074/jbc.M115.662114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M115.662114</ArticleId>
            <ArticleId IdType="pmc">PMC4536441</ArticleId>
            <ArticleId IdType="pubmed">26152715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Won J.H., Park S., Hong S., Son S., Yu J.W. Rotenone-induced impairment of mitochondrial electron transport chain confers a selective priming signal for NLRP3 inflammasome activation. J. Biol. Chem. 2015;290:27425–27437. doi: 10.1074/jbc.M115.667063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M115.667063</ArticleId>
            <ArticleId IdType="pmc">PMC4646374</ArticleId>
            <ArticleId IdType="pubmed">26416893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y., Zhu H., Kuppusamy P., Zweier J.L., Trush M.A. Mitochondrial electron transport chain-derived superoxide exits macrophages: Implications for mononuclear cell-mediated pathophysiological processes. React. Oxyg. Species. 2016;1:81–98. doi: 10.20455/ros.2016.815.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.20455/ros.2016.815</ArticleId>
            <ArticleId IdType="pmc">PMC5268359</ArticleId>
            <ArticleId IdType="pubmed">28133629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X., Zhang X., Ding Y., Zhou W., Tao L., Lu P., Wang Y., Hu R. Nuclear factor E2-related factor-2 negatively regulates NLRP3 inflammasome activity by inhibiting reactive oxygen species-induced NLRP3 priming. Antioxid. Redox Signal. 2017;26:28–43. doi: 10.1089/ars.2015.6615.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2015.6615</ArticleId>
            <ArticleId IdType="pmc">PMC5198158</ArticleId>
            <ArticleId IdType="pubmed">27308893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandel N.S., Trzyna W.C., McClintock D.S., Schumacker P.T. Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J. Immunol. 2000;165:1013–1021. doi: 10.4049/jimmunol.165.2.1013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.165.2.1013</ArticleId>
            <ArticleId IdType="pubmed">10878378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woo C.H., Lim J.H., Kim J.H. Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. J. Immunol. 2004;173:6973–6980. doi: 10.4049/jimmunol.173.11.6973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.173.11.6973</ArticleId>
            <ArticleId IdType="pubmed">15557194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu X., Gao H., Hou Y., Yu J., Sun W., Wang Y., Chen X., Feng Y., Xu Q.M., Chen X. Dihydronortanshinone, a natural product, alleviates LPS-induced inflammatory response through NF-kappaB, mitochondrial ROS, and MAPK pathways. Toxicol. Appl. Pharmacol. 2018;355:1–8. doi: 10.1016/j.taap.2018.06.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.taap.2018.06.007</ArticleId>
            <ArticleId IdType="pubmed">29906494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fassone E., Rahman S. Complex I deficiency: Clinical features, biochemistry and molecular genetics. J. Med. Genet. 2012;49:578–590. doi: 10.1136/jmedgenet-2012-101159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmedgenet-2012-101159</ArticleId>
            <ArticleId IdType="pubmed">22972949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calvaruso M.A., Willems P., van den Brand M., Valsecchi F., Kruse S., Palmiter R., Smeitink J., Nijtmans L. Mitochondrial complex III stabilizes complex I in the absence of NDUFS4 to provide partial activity. Hum. Mol. Genet. 2012;21:115–120. doi: 10.1093/hmg/ddr446.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddr446</ArticleId>
            <ArticleId IdType="pubmed">21965299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leong D.W., Komen J.C., Hewitt C.A., Arnaud E., McKenzie M., Phipson B., Bahlo M., Laskowski A., Kinkel S.A., Davey G.M., et al.  Proteomic and metabolomic analyses of mitochondrial complex I-deficient mouse model generated by spontaneous B2 short interspersed nuclear element (SINE) insertion into NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) gene. J. Biol. Chem. 2012;287:20652–20663. doi: 10.1074/jbc.M111.327601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.327601</ArticleId>
            <ArticleId IdType="pmc">PMC3370248</ArticleId>
            <ArticleId IdType="pubmed">22535952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kruse S.E., Watt W.C., Marcinek D.J., Kapur R.P., Schenkman K.A., Palmiter R.D. Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. Cell Metab. 2008;7:312–320. doi: 10.1016/j.cmet.2008.02.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2008.02.004</ArticleId>
            <ArticleId IdType="pmc">PMC2593686</ArticleId>
            <ArticleId IdType="pubmed">18396137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang M., Huang Y.P., Wu H., Song K., Wan C., Chi A.N., Xiao Y.M., Zhao X.Y. Mitochondrial complex I deficiency leads to the retardation of early embryonic development in Ndufs4 knockout mice. PeerJ. 2017;5:e3339. doi: 10.7717/peerj.3339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7717/peerj.3339</ArticleId>
            <ArticleId IdType="pmc">PMC5438584</ArticleId>
            <ArticleId IdType="pubmed">28533980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin Z., Wei W., Yang M., Du Y., Wan Y. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell Metab. 2014;20:483–498. doi: 10.1016/j.cmet.2014.07.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2014.07.011</ArticleId>
            <ArticleId IdType="pmc">PMC4156549</ArticleId>
            <ArticleId IdType="pubmed">25130399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang S., Rutkowsky J.M., Snodgrass R.G., Ono-Moore K.D., Schneider D.A., Newman J.W., Adams S.H., Hwang D.H. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J. Lipid Res. 2012;53:2002–2013. doi: 10.1194/jlr.D029546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1194/jlr.D029546</ArticleId>
            <ArticleId IdType="pmc">PMC3413240</ArticleId>
            <ArticleId IdType="pubmed">22766885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vogel R.O., Janssen R.J., van den Brand M.A., Dieteren C.E., Verkaart S., Koopman W.J., Willems P.H., Pluk W., van den Heuvel L.P., Smeitink J.A., et al.  Cytosolic signaling protein Ecsit also localizes to mitochondria where it interacts with chaperone NDUFAF1 and functions in complex I assembly. Genes Dev. 2007;21:615–624. doi: 10.1101/gad.408407.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.408407</ArticleId>
            <ArticleId IdType="pmc">PMC1820902</ArticleId>
            <ArticleId IdType="pubmed">17344420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carneiro F.R.G., Lepelley A., Seeley J.J., Hayden M.S., Ghosh S. An essential role for ECSIT in mitochondrial complex i assembly and mitophagy in macrophages. Cell Rep. 2018;22:2654–2666. doi: 10.1016/j.celrep.2018.02.051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2018.02.051</ArticleId>
            <ArticleId IdType="pmc">PMC5909989</ArticleId>
            <ArticleId IdType="pubmed">29514094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wi S.M., Moon G., Kim J., Kim S.T., Shim J.H., Chun E., Lee K.Y. TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-kappaB. J. Biol. Chem. 2014;289:35205–35214. doi: 10.1074/jbc.M114.597187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M114.597187</ArticleId>
            <ArticleId IdType="pmc">PMC4271209</ArticleId>
            <ArticleId IdType="pubmed">25371197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bleier L., Drose S. Superoxide generation by complex III: From mechanistic rationales to functional consequences. Biochim. Biophys. Acta. 2013;1827:1320–1331. doi: 10.1016/j.bbabio.2012.12.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbabio.2012.12.002</ArticleId>
            <ArticleId IdType="pubmed">23269318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zmijewski J.W., Lorne E., Banerjee S., Abraham E. Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009;296:L624–L634. doi: 10.1152/ajplung.90522.2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajplung.90522.2008</ArticleId>
            <ArticleId IdType="pmc">PMC2670767</ArticleId>
            <ArticleId IdType="pubmed">19168575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feingold K.R., Shigenaga J.K., Kazemi M.R., McDonald C.M., Patzek S.M., Cross A.S., Moser A., Grunfeld C. Mechanisms of triglyceride accumulation in activated macrophages. J. Leukoc. Biol. 2012;92:829–839. doi: 10.1189/jlb.1111537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.1111537</ArticleId>
            <ArticleId IdType="pmc">PMC3441312</ArticleId>
            <ArticleId IdType="pubmed">22753953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Posokhova E.N., Khoshchenko O.M., Chasovskikh M.I., Pivovarova E.N., Dushkin M.I. Lipid synthesis in macrophages during inflammation in vivo: Effect of agonists of peroxisome proliferator activated receptors alpha and gamma and of retinoid X receptors. Biochem. Biokhimiia. 2008;73:296–304. doi: 10.1134/S0006297908030097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1134/S0006297908030097</ArticleId>
            <ArticleId IdType="pubmed">18393765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ecker J., Liebisch G., Englmaier M., Grandl M., Robenek H., Schmitz G. Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc. Natl. Acad. Sci. USA. 2010;107:7817–7822. doi: 10.1073/pnas.0912059107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0912059107</ArticleId>
            <ArticleId IdType="pmc">PMC2867858</ArticleId>
            <ArticleId IdType="pubmed">20385828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carroll R.G., Zaslona Z., Galvan-Pena S., Koppe E.L., Sevin D.C., Angiari S., Triantafilou M., Triantafilou K., Modis L.K., O’Neill L.A. An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation. J. Biol. Chem. 2018;293:5509–5521. doi: 10.1074/jbc.RA118.001921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.RA118.001921</ArticleId>
            <ArticleId IdType="pmc">PMC5900750</ArticleId>
            <ArticleId IdType="pubmed">29463677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Divakaruni A.S., Hsieh W.Y., Minarrieta L., Duong T.N., Kim K.K.O., Desousa B.R., Andreyev A.Y., Bowman C.E., Caradonna K., Dranka B.P., et al.  Etomoxir inhibits macrophage polarization by disrupting CoA homeostasis. Cell Metab. 2018;28:490–503. doi: 10.1016/j.cmet.2018.06.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2018.06.001</ArticleId>
            <ArticleId IdType="pmc">PMC6125190</ArticleId>
            <ArticleId IdType="pubmed">30043752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang S.C., Everts B., Ivanova Y., O’Sullivan D., Nascimento M., Smith A.M., Beatty W., Love-Gregory L., Lam W.Y., O’Neill C.M., et al.  Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 2014;15:846–855. doi: 10.1038/ni.2956.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.2956</ArticleId>
            <ArticleId IdType="pmc">PMC4139419</ArticleId>
            <ArticleId IdType="pubmed">25086775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hossain F., Al-Khami A.A., Wyczechowska D., Hernandez C., Zheng L., Reiss K., Valle L.D., Trillo-Tinoco J., Maj T., Zou W., et al.  Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies. Cancer Immunol. Res. 2015;3:1236–1247. doi: 10.1158/2326-6066.CIR-15-0036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/2326-6066.CIR-15-0036</ArticleId>
            <ArticleId IdType="pmc">PMC4636942</ArticleId>
            <ArticleId IdType="pubmed">26025381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Namgaladze D., Brune B. Fatty acid oxidation is dispensable for human macrophage IL-4-induced polarization. Biochim. Biophys. Acta. 2014;1841:1329–1335. doi: 10.1016/j.bbalip.2014.06.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbalip.2014.06.007</ArticleId>
            <ArticleId IdType="pubmed">24960101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nomura M., Liu J., Rovira I.I., Gonzalez-Hurtado E., Lee J., Wolfgang M.J., Finkel T. Fatty acid oxidation in macrophage polarization. Nat. Immunol. 2016;17:216–217. doi: 10.1038/ni.3366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.3366</ArticleId>
            <ArticleId IdType="pmc">PMC6033271</ArticleId>
            <ArticleId IdType="pubmed">26882249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koeken V., Lachmandas E., Riza A., Matzaraki V., Li Y., Kumar V., Oosting M., Joosten L.A.B., Netea M.G., van Crevel R. Role of glutamine metabolism in host defense against mycobacterium tuberculosis infection. J. Infect. Dis. 2019;219:1662–1670. doi: 10.1093/infdis/jiy709.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiy709</ArticleId>
            <ArticleId IdType="pubmed">30541099</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
